Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Rush University Medical Center
mi
from
Chicago, IL
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Brain Stimulation Chicago North Shore
mi
from
Northbrook, IL
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Brain Stimulation Chicago North Shore
mi
from
Northbrook, IL
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Behavioral Health Care Associates
mi
from
Schaumburg, IL
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Behavioral Health Care Associates
mi
from
Schaumburg, IL
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
University Psychiatric Foundation
mi
from
Louisville, KY
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
University Psychiatric Foundation
mi
from
Louisville, KY
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Integrative Psychiatry
mi
from
Louisville, KY
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Integrative Psychiatry
mi
from
Louisville, KY
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Spectrum Behavioral Health
mi
from
Annapolis, MD
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Spectrum Behavioral Health
mi
from
Annapolis, MD
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Anthony Drobnick, MD
mi
from
St. Michaels, MD
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Anthony Drobnick, MD
mi
from
St. Michaels, MD
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Newton-Wellesley Psychiatry
mi
from
Newton, MA
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Newton-Wellesley Psychiatry
mi
from
Newton, MA
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Central Psychiatry
mi
from
Las Vegas, NV
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Central Psychiatry
mi
from
Las Vegas, NV
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
TMS Center of New England
mi
from
Portsmouth, NH
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
TMS Center of New England
mi
from
Portsmouth, NH
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Santa Fe TMS Therapy Center
mi
from
Santa Fe, NM
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Santa Fe TMS Therapy Center
mi
from
Santa Fe, NM
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Dent Neurosciences Research Center
mi
from
Amherst, NY
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Dent Neurosciences Research Center
mi
from
Amherst, NY
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
The TMS Institute of Pennsylvania-Advanced Neuropsychiatric Solutions
mi
from
West Chester, PA
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
The TMS Institute of Pennsylvania-Advanced Neuropsychiatric Solutions
mi
from
West Chester, PA
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Butler Hospital
mi
from
Providence, RI
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
W. Scott West, M.D.
mi
from
Nashville, TN
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
W. Scott West, M.D.
mi
from
Nashville, TN
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Texas Neuropsychiatric Institute
mi
from
Amarillo, TX
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Texas Neuropsychiatric Institute
mi
from
Amarillo, TX
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Texas TMS Center at Senior Adults Specialty Healthcare (SASH)
mi
from
Austin, TX
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Texas TMS Center at Senior Adults Specialty Healthcare (SASH)
mi
from
Austin, TX
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Houston TMS
mi
from
Houston, TX
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Houston TMS
mi
from
Houston, TX
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Agape Mind Services/The Costello Clinic
mi
from
Lewisville, TX
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Agape Mind Services/The Costello Clinic
mi
from
Lewisville, TX
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Serenity Center for Depression, P.A.
mi
from
Sugar Land, TX
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Serenity Center for Depression, P.A.
mi
from
Sugar Land, TX
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
University Neuropsychiatric Institute
mi
from
Salt Lake City, UT
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
University Neuropsychiatric Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated:  11/11/2015
Center for Anxiety and Depression
mi
from
Mercer Island, WA
NeuroStar TMS Therapy System: Utilization and Outcomes
NeuroStar TMS Therapy System: Data Management, Analysis and Reporting Format for Clinical Treatment Utilization and Outcomes (Protocol no. 19-50001-000,Rev D
Status: Enrolling
Updated: 11/11/2015
Center for Anxiety and Depression
mi
from
Mercer Island, WA
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Rush University Medical Center
mi
from
Chicago, IL
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Premier Psychiatric Group, LLC
mi
from
Lincoln, NE
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Premier Psychiatric Group, LLC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Butler Hospital
mi
from
Providence, RI
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Medical University of South Carolina
mi
from
Charleston, SC
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  11/11/2015
Center for Anxiety and Depression
mi
from
Mercer Island, WA
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
A 12-Month Prospective Randomized Dual-Arm Pilot Study of Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 11/11/2015
Center for Anxiety and Depression
mi
from
Mercer Island, WA
Click here to add this to my saved trials
Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
Survey of the Quality of Life of Women
Status: Enrolling
Updated:  11/12/2015
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
Survey of the Quality of Life of Women
Status: Enrolling
Updated: 11/12/2015
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Birmingham Psychiatry Pharmaceutical Studies, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Synergy Clinical Research Center
mi
from
Escondido, CA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Synergy Clinical Research Center
mi
from
Escondido, CA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Stanford -VA Palo Alto Health Care System
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Clinical Innovations Inc.
mi
from
Riverside, CA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Clinical Innovations Inc.
mi
from
Riverside, CA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Florida Clinical Research Center, LLC
mi
from
Sarasota, FL
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Massachusetts General Hospital - Center for Anxiety and Traumatic Stress Disorders
mi
from
Boston, MA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
St Charles Psychiatric Associates - Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Social Psychiatric Research Inst. (SPRI) Clinical Trials
mi
from
Brooklyn, NY
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Social Psychiatric Research Inst. (SPRI) Clinical Trials
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Village Clinical Research Inc.
mi
from
New York, NY
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Behavioral Medical Research of Staten Island
mi
from
Staten Island, NY
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Psychiatry and Behavioral Sciences, Duke
mi
from
Durham, NC
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
CRI Worldwide - Kirkbride
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Dept. of Psychiatry, UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/13/2015
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/13/2015
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials